Vaccine News and Research

Latest Vaccine News and Research

More than 40 groups join together to oppose Senate healthcare bill, hold online Virtual Vigil

More than 40 groups have joined together to oppose the Senate healthcare bill, and will hold an online "Virtual Vigil" starting at 9 pm tonight and wrapping after the Senate votes around 1 am.

21 Dec 2009

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

An experiemental nasally administered malaria vaccine prevented parasite transmission from infected mice to mosquitoes and could play an important role in the fight against human malaria. The researchers from Japan report their findings in the December 2009 issue of the journal Infection and Immunity.

19 Dec 2009

Second wave of H1N1 virus infection in the U.S. comes to an end

Rates of 2009 H1N1 influenza virus testing in the U.S. have declined more than 75 percent since their peak in late October, suggesting that the "second wave" of virus infection that sickened tens of millions of Americans since it began four months ago may be coming to an end, according to a new report by Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services.

19 Dec 2009

SCCA's infection control program leads to suppression of potential H1N1 pandemic

Despite a 100-fold increase in H1N1 influenza cases in the Seattle area during spring 2009, an aggressive infection control program to protect immunocompromised cancer patients and thorough screening measures resulted in no corresponding increase in H1N1 cases among the total patient population at the Seattle Cancer Care Alliance, according to a new study by researchers and physicians at Fred Hutchinson Cancer Research Center and the SCCA.

19 Dec 2009

Akorn exits vaccine distribution business

Akorn, Inc. today announced that it failed to reach an amicable resolution to a longer term and strategic business arrangement with the supplier of its Tetanus Diphtheria (“Td”) vaccine and as a result will be exiting the business. The existing supply agreement will end on March 14, 2010. The company previously announced its intent to exit the distribution of flu vaccines.

19 Dec 2009

MinuteClinic medical clinics in select CVS/pharmacy stores offer H1N1 vaccinations

MinuteClinic medical clinics in select CVS/pharmacy stores throughout Maryland, North Carolina and Tennessee are now offering H1N1 vaccinations on demand seven days a week with no appointment necessary.

19 Dec 2009

Sanofi Pasteur pediatric H1N1 vaccine recall: No danger and no need of an extra dose

There is no danger if your child received the H1N1 vaccine that was recalled by Sanofi Pasteur. That is the information being provided to anyone calling the NJ Poison Control Center's hotline, according to Bruce Ruck, Pharm.D., Director of Drug Information and Professional Education. The public should be reassured that this recall took place because specific lots were found to be slightly weaker than they should have been.

19 Dec 2009

Recent releases in Global Health

A Scientific American article examines recent efforts to tackle neglected tropical diseases (NTDs). The author writes "NTDs have plagued humankind for thousands of years. … What is new, however, is that donors, drugmakers, health ministries in low- and middle-income countries, the World Health Organization (WHO), and public-private partnerships are linking their efforts to combat the NTDs in a more coordinated and systematic way."

18 Dec 2009

Opinion: Uganda anti-gay bill; Shah confirmation

Columnist Michael Gerson in a Washington Post opinion piece writes of Uganda's Anti-Homosexuality Bill of 2009 being considered by the country's parliament "that would impose new and harsher penalties on homosexuality, including life imprisonment and capital punishment. It also would force pastors and others to report homosexuals to the authorities.

18 Dec 2009

National Journal examines USAID administrator nominee's experience, prospects at the Agency

The National Journal looks at the professional background of Rajiv Shah, President Barack Obama's nominee to be the USAID administrator. "As Rajiv Shah prepares to lead the U.S. Agency for International Development, former colleagues, lobbyists and current and past administration officials paint a picture of a man with dizzying brainpower and social intelligence who has won over skeptics time and again.

18 Dec 2009

H1N1 cases still increasing in many countries; WHO to begin shipping donated vaccines within weeks

With many countries continuing to report a growing number of H1N1 (swine flu) cases, Keiji Fukuda, special adviser to the WHO director general on pandemic influenza, said Thursday it was too early to declare the pandemic over, the Washington Post reports.

18 Dec 2009

EMA's CHMP issues positive opinion for Cangene's Human Hepatitis B Immunoglobulin product

Cangene Corporation today reports that it has received a positive opinion from the EMA's Committee for Medicinal Products for Human Use ("CHMP") regarding the immunoprophylaxis indication of Cangene's ImmunoGam(TM) (Human Hepatitis B Immunoglobulin).

18 Dec 2009

Human protein may help prevent H1N1 infection

Howard Hughes Medical Institute researchers have identified a naturally occurring human protein that helps prevent infection by H1N1 influenza and other viruses, including West Nile and dengue virus.

18 Dec 2009

Liquidia Technologies to receive $3 million in funding from NIST

Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department’s National Institute of Standards and Technology (NIST) to further develop and scale-up the company’s PRINT manufacturing process.

18 Dec 2009

BDI Pharma introduces SecuriVAX for online ordering of vaccines

BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced today the introduction of SecuriVAX(SM) (www.securivax.com), an online supply solution providing the healthcare community a one-stop source for a wide variety of vaccines.

18 Dec 2009

Flu-fighting proteins found in human cells stop flu virus, uncover scientists

In findings that may lead to better ways to prevent and treat influenza and other viral infections, researchers report the discovery of a family of naturally occurring antiviral agents in human cells.

18 Dec 2009

Comprehensive approaches to understand the interaction of H1N1 strains with human cells

Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.

18 Dec 2009

Duane Reade offers H1N1 immunization vaccines for New York residents

Duane Reade, the largest drug store chain in New York City, today announced plans for its H1N1 immunization program as part of the Company's commitment to meet the health and wellness needs of New Yorkers and to be a destination for their flu related needs.

18 Dec 2009

Also in Global Health news: Hospital births in Guinea-Bissau; drought in E. Africa; drug-resistant malaria; U.S. response to H1N1

IRIN examines the increase in the number of women giving birth in hospital settings rather than delivery by a traditional birth attendant - a behavior that health officials hope will lead to a drop in the country's maternal mortality rate. "According to UNFPA, 38 percent of women gave birth in a hospital in 2009, up from 29 percent in 2003," the news service writes.

17 Dec 2009

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus -- in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.

17 Dec 2009

Vaccine News and Research

Latest Vaccine News and Research

More than 40 groups join together to oppose Senate healthcare bill, hold online Virtual Vigil

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

Second wave of H1N1 virus infection in the U.S. comes to an end

SCCA's infection control program leads to suppression of potential H1N1 pandemic

Akorn exits vaccine distribution business

MinuteClinic medical clinics in select CVS/pharmacy stores offer H1N1 vaccinations

Sanofi Pasteur pediatric H1N1 vaccine recall: No danger and no need of an extra dose

Recent releases in Global Health

Opinion: Uganda anti-gay bill; Shah confirmation

National Journal examines USAID administrator nominee's experience, prospects at the Agency

H1N1 cases still increasing in many countries; WHO to begin shipping donated vaccines within weeks

EMA's CHMP issues positive opinion for Cangene's Human Hepatitis B Immunoglobulin product

Human protein may help prevent H1N1 infection

Liquidia Technologies to receive $3 million in funding from NIST

BDI Pharma introduces SecuriVAX for online ordering of vaccines

Flu-fighting proteins found in human cells stop flu virus, uncover scientists

Comprehensive approaches to understand the interaction of H1N1 strains with human cells

Duane Reade offers H1N1 immunization vaccines for New York residents

Also in Global Health news: Hospital births in Guinea-Bissau; drought in E. Africa; drug-resistant malaria; U.S. response to H1N1

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in